PIMREG and cancer: Phosphatidylinositol binding clathrin assembly protein interacting mitotic regulator (PIMREG, also referred to as CATS, RCS1, and FAM64A) has been verified to regulate the transition from mid to late cell division and is a biomarker of proliferation, suggesting an action in the development of cancer cells (3–5).